Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study is a Dose block-randomized, Double-blind, Placebo-controlled, Single and Multiple
Ascending Dose Escalation, Phase I clinical trial to assess the safety, tolerability and
pharmacokinetics of single-dose and multiple-dose oral administration of the investigational
product, EC-18 (study drug) in healthy adult male volunteers.